loader
 

PROCESS VALIDATION & CONTINUED VERIFICATION

Loading Events

« All Events

Continued Verification * Master Planning * Risk * Statistics * Change Control * Data Integrity

March 30 - April 1

Philadelphia, United States



Process Validation & Continued Process Verification (CPV)

 

Process Validation is the backbone of all validation and is always under FDA regulatory scrutiny. KENX is excited to announce the definitive process validation and continued process verification conference of 2019. This event gives you the tools and technology needed to create, deploy and maintain best practices through all three stages of validation. Come to Philadelphia this spring and align with best-in-class case studies that impress FDA investigators and make an immediate impact for your organization and professional career.

 

Top 10 Reasons to Attend:

  • Walk through a risk-based implementation case study
  • Master the Validation Master Plan (VMP)
  • Establish a compliant Continued Process Verification (CPV) process
  • Uncover the top 5 challenges
  • Leverage technology transfer and engineering studies
  • Discover a Quality by Design (QbD) approach
  • Process Performance Qualification (PPQ) – Select the optimal sampling plan
  • Develop a gap analysis checklist for your program
  • Understand how to use statistics in process validation
  • Learn an effective approach for combination products

 

Personnel in the Following Environments Should Attend:

  • Validation
  • QA/QC
  • Engineering
  • Regulatory Affairs
  • Compliance
  • Manufacturing
  • Laboratory

 

This event is also appropriate to business development and sales managers that offer innovative solutions for change control, risk management, statistics and validation.

 

 

Agenda

  • 12:00
    Conference Registration
    Coffee & Tea
  • 1:15
    Chairperson’s Opening Remarks
  • 1:30
    FDA Insight – Agency Updates and Compliance Trends
    James Mason, PharmD, Compliance Officer, OPQO, U.S. FDA
  • 2:00
    Optimize Your Validation Efforts Using Quality Risk Management
    Lelia Scott, Executive Director, Global Quality Systems, Charles River Laboratories
  • 2:30
    Accelerate Process Validation with Data-Based Quality by Design
    Ronald D. Snee, Ph.D., Founder and President, Snee Associates, LLC
  • 3:00
    Networking Refreshment Break
  • 3:30
    Lean Validation – Ensure Quality While Reducing Cost
    Phil Jarvis, Global C&Q lead for EU, Abbvie
  • 4:00
    Build a Streamlined Audit Trail Review Process
    Matthew LaPierre, Data Integrity Specialist, Industry Expert
  • 4:30
    Examining Validation Training Effectiveness
    Danielle Duran, Senior Manager, Training and Development, Site Business Operations, BioMarin Pharmaceutical
  • 5:15
    Networking & Welcome Reception
  • 7:00
    Coffee and Lite Breakfast
  • 7:30 - 8:15
    Select Between Knowledge Exchange Sessions (1-4)
  • 1
    Change Control in Validation – Managing Like-for-Like Changes
    Donnacha Nagle; Researcher TU Dublin; Validation Lead, Eirchem Pharmaceuticals
  • 2
    Validation Risk Assessment – Develop a Practical and Pragmatic Program
    Roque Redondo, VP Automation & Business Development, Mirus Consulting Group
  • 3
    Risk-Based Equipment Qualification
    Chip Bennett, Assistant Director, Global C&Q, CAI
  • 4
    Detecting the Lack of Data Integrity
    Ronald D. Snee, Ph.D., Founder and President, Snee Associates, LLC
  • 8:30 – 10:00
    Select Between Knowledge Exchange Sessions (5-8)
  • 5
    The Validation Master Plan (VMP) – Plans That Impress Investigators
    Connie Hetzler, Global Head – Validation, Alcon Laboratories
  • 6
    Risk-Based Cleaning Validation – Key Elements to a Successful Program
    Chip Bennett, Assistant Director, Global C&Q, CAI
  • 7
    Handle Validation Inspections and Respond to Regulatory Findings
    Kim Huynh-Ba, Managing Director, Pharmalytik; Adjunct Faculty, RAQA Graduate Program, Temple University; Council of Expert, USP
  • 8
    Cultivate and Maintain the Culture of Integrity in Data Management
    Peju Odunusi, Ph.D., Group Leader, Abbott
  • 10:00
    Mid-Morning Refreshment Break
  • 10:30 - 12:00
    Select Between Knowledge Exchange Sessions (9-12)
  • 9
    Implement a Risk-Based Process Validation Program Enterprise-wide
    Phil Jarvis, Global C&Q lead for EU, Abbvie
  • 10
    Validation Statistics with Confidence and The Arts of Charts
    Ronald D. Snee, Ph.D., Founder and President, Snee Associates, LLC
  • 11
    A Cost Effective and Practical Approach to Risk-Based CSV
    Michael Brunner, Computer Systems Validation Specialist, Upsher-Smith Laboratories, Inc.
  • 12
    Homo Sapiens atque Integritas Notitia, Expanded Edition – Human Beings and Data Integrity
    J Loren Smith, Senior Manager, Global Compliance & Ethics, BioMarin Pharmaceutical
  • 12:00
    Grab & Go Lunch & Learns (13-16)
  • 13
    Analytical Methods Validation for QA and Validation Professionals
    Kim Huynh-Ba, Managing Director, Pharmalytik; Adjunct Faculty, RAQA Graduate Program, Temple University; Council of Expert, USP
  • 14
    Right Size Sampling and Statistics for PPQ
    Katherine Giacoletti, Partner, SynoloStats
  • 15
    Documentation Requirements for Successful Validation
    Alan Golden, MS, Principal, Design Quality Consultants, LLC
  • 16
    Navigate the Maze of Data Integrity Regulations
    Roque Redondo, VP Automation & Business Development, Mirus Consulting Group
  • 1:15 - 2:45
    Select Between Knowledge Exchange Breakfasts (17-20)
  • 17
    Risk-based Approaches to IQ/OQ/PQ Project Management
    Patrick Mullin, Senior CQV, QAV Account Manager, DPS Global
  • 18
    Single Use Systems (SUSs) – Implementation and Validation
    Steven S. Kuwahara, Ph.D., Principal Consultant, GXP BioTechnology
  • 19
    Implement a Data Infrastructure for Advanced Analytics
    Eric S. Collier, Assistant Director, Automation and IT, CAI
  • 20
    Data Integrity Risk Assessment Across the Data Lifecycle
    Chinmoy Roy, Senior Industry Consultant, VALGENESIS
  • 2:45
    Afternoon Refreshment Break
  • 3:00 - 4:45
    Select Between Knowledge Exchange Sessions (21-24)
  • 21
    Risk-Based Critical Cleaning Process Parameter and Critical Quality Attributes – A Case Study
    Phil Jarvis, Global C&Q lead for EU, Abbvie
  • 22
    Environmental Monitoring and HVAC System Validation
    Gamal Amer, Ph.D. Principal, Premier Compliance Services
  • 23
    Statistics for Risk Management Across the Product Lifecycle
    Katherine Giacoletti, Partner, SynoloStats
  • 24
    Validation of Mobile Applications
    Raul Soto, Senior Principal Engineer, Johnson & Johnson Vision Care
  • 4:45
    Day Two Closing Session
  • FDA’s Proposed Computer Software Assurance Guidance
    Kevin Martin, General Manager & Managing Partner, Azzur Group LLC; Senthil Gurumoorthi, Associate Director, Gilead Sciences; Ken Shitamoto, Senior Director, Gilead Sciences
  • 7:00
    Coffee and Lite Breakfast
  • 7:30 - 8:15
    Select Between Knowledge Exchange Sessions (25-28)
  • 25
    Qualify Utilities – Water Systems, Clean Steam and Process Gases
    Steven S. Kuwahara, Ph.D., Principal Consultant, GXP BioTechnology
  • 26
    Batch Record Process Automation Using AI for BioPharma
    Abhijit Ray, Chief Digital Architect, Aventior, Inc.
  • 27
    Data Integrity Audit Preparation – Before and After
    Peju Odunusi, Ph.D., Stability Group Leader, Abbott
  • 8:30 – 10:00
    Select Between Knowledge Exchange Sessions (29-32)
  • 29
    Conduct Risk-Based Revalidations and Periodic Reviews of Systems
    Donnacha Nagle; Researcher TU Dublin; Validation Lead, Eirchem Pharmaceuticals
  • 30
    Autoclave Validation - Periodic Benchmark Testing
    Chris Maughan, Managing Director and Autoclave SME, Thermal Compliance Ltd
  • 31
    Conduct a Site-Wide Validation Gap Assessment
    Connie Hetzler, Global Head – Validation, Alcon Laboratories
  • 32
    Overcome the Top Challenges of Data Integrity Implementation
    Matthew LaPierre, Data Integrity Specialist, Industry Expert
  • 10:00
    Mid-Morning Refreshment Break
  • 10:30 – 12:00
    Select Between Knowledge Exchange Sessions (33-36)
  • 33
    Cleaning Validation – Documents, SOPs and Strategies
    Fred Ohsiek, Senior Cleaning Validation Specialist, Novo Nordisk
  • 34
    Equipment Calibration – Measurements, Documentation and Project Management
    TBD, Ellab
  • 35
    Medical Device Validation & Verification Master Class
    Alan Golden, Senior CSV and Compliance Manager, Design Quality Consultants, LLC
  • 36
    Develop a Validation Strategy for Intelligent Automation
    Rosalind Beasley, Digital Transformation Leader, ROQMetrics, Inc.
  • 12:00
    Grab & Go Lunch & Learns (37-39)
  • 37
    Creating an Effective Supplier Quality Agreement
    Gamal Amer, Ph.D. Principal, Premier Compliance Services
  • 38
    Current Trends in Cleanroom Validation
    David W. Vincent, Ph.D., CEO, VTI Life Sciences
  • 39
    Transition from Paper to Electronic Validation – Overcome the Challenges
    Kim Munsell, Sr Computer Systems Validation & Compliance Manager, Janssen R&D
  • 1:00 - 2:30
    Select Between Knowledge Exchange Sessions (40-42)
  • 41
    Streamline CSV Processes Across Multiple Sites and Cultures
    Lelia Scott, Executive Director, Global Quality Systems, Charles River Laboratories
  • 42
    Construct and Analyze Validation Control Charts
    Anthony Chikere, Senior Manager, Bayer Pharmaceutical
  • 43
    Conduct a Gap Analysis of Computer Systems and Data Integrity
    Patrick Mullin, Senior CQV, QAV Account Manager, DPS Global
  • 2:30
    Afternoon Refreshment Break
  • 2:45 - 4:15
    Select Between Knowledge Exchange Sessions (43-44)
  • 44
    Key Considerations for Process Validation and Successful Tech Transfer
    David W. Vincent, Ph.D., CEO, VTI Life Sciences
  • 45
    Validating GXP Spreadsheets
    Raul Soto, Senior Principal Software Engineer, Johnson & Johnson Vision Care
  • 4:30
    Close of Conference

Faculty

  • Michael Brunner, CSV Specialist, Upsher-Smith

    Mr. Brunner is experienced with over 14 years of experience in all areas of validation including; equipment validation, facilities validation, CSV and 21 CFR Part 11, and test method validation. Through strategic thinking, he has success in steering and managing complex validation projects within the medical device and pharmaceutical industries.
  • Gamal Amer, Principal, Premier Compliance Services

    Dr. Amer, a chemical engineer by training, has 40 years-experience in the pharmaceutical and related industries. He has held senior management positions with leading pharmaceutical, consumer products, and engineering consulting companies. His experience includes comprehensive process design in bulk pharmaceutical chemicals manufacturing, biotechnology manufacturing, pharmaceutical solid dosage manufacturing, and containment of potent and radioactive therapeutics. He is also experienced with facility development for therapeutic products operations. Dr. Amer is a recognized expert in GMP compliance and validation.
  • Chip Bennett, Assistant Director, CAI

    Chip Bennett, Assistant Director, Global C&Q, CAI is a QRM SME and lead CQV Program Development SME. A Project Manager and Senior Validation Engineer, Chip is a PMI® Certified Project Management Professional (PMP) with 20 years of experience in the pharmaceutical and regulated non-pharmaceutical industries and with expertise in risk-based verification, aseptic manufacturing, cleaning validation, quality systems, and owner project management. Chip is responsible for developing and implementing Quality Risk Management (QRM) based Commissioning and Qualification programs and projects, with a particular focus on assessing and training clients regarding development, implementation, and transition to risk-based approaches.
  • Anthony Chikere, Senior Manager Process Validation/Cleaning And CPV, Bayer HealthCare, Berkeley

    Dr. Anthony Chikere is an experienced scientist with over 15 years of experience in different areas of Biopharmaceutical production including: process development, process monitoring and control, process validation and quality assurance. Since 2017, he is responsible for managing the Continuous Process Verification (CPV) program at Bayer HealthCare in Berkeley.
  • Eric Collier, Discipline Lead Automation And IT, Commissioning Agents, Inc.

    Mr. Collier is an experienced leader with more than 27 years as a project manager, software engineer, and IT consult. More than 17 of those years have been spent in the Pharmaceutical, Biopharmaceutical and Medical Device industries leading 21 CFR Part 11, Computer System Validation (CSV), Data Integrity, and Good Automated Manufacturing Practice (GAMP) assessment, implementation, compliance, and remediation projects.
  • Danielle, Duran, Senior Manager, Training and Development, Site Bus, BioMarin Pharmaceutical

    Danielle has worked in learning and continuous improvement program management in biotechnology, tech-startups, k-16 education, philanthropy, and non-profit. Her expertise is leveraging an understanding of how learning is understood from a neurological perspective combined with how we understand behavior and social interactions to drive meaningful change. Danielle has provided leadership to a research team investigating the use of varied sets of data to predict human performance and a team developing and validating very large-scale knowledge assessments to predict performance. She has also taught assessment design at the graduate level. She is currently leading a global initiative to improve aspects of the training system, standards, and procedures. She enjoys learning, supporting the meaningful development of others, and advising leaders on how to catalyze their talent.
  • Katherine Giacoletti, Partner, SynoloStats, LLC

    Katherine has worked as a statistician in the Pharmaceutical industry for over 17 years and has expertise across the product lifecycle, from product and process development through validation and commercial supply, as well as all stages of clinical development from First in Human through licensure and beyond. She holds a Master of Statistics from North Carolina State University, with a focus in biostatistics. Katherine lives and works in the Philadelphia suburbs with her husband and daughter and 2 cats, and in her spare time is a dancer and a teacher of Scottish dancing.
  • Alan M Golden, Principal, Design Quality Consultants

    Alan has over 30 years of experience in the medical device industry, both in basic research and in quality assurance. Alan spent 31 years at Abbott Laboratories. For the first 16 years as part of diagnostics R&D, he developed recombinant proteins used in diagnostics tests, received three US patents and published numerous papers and abstracts. Alan then transitioned to a quality assurance role where in both the Abbott Diagnostics and Abbott Molecular divisions, he was responsible for quality assurance for new product development, on-market product support and operations. Alan’s quality assurance experience extends from design control, change control, risk management, CAPA, process and test method validation and statistics. He has been lecturing on these topics worldwide for over 10 years.
  • Senthil Gurumoorthi MS MBA, Associate Director IT, Gilead Sciences

    Senthil Gurumoorthi leads IT Quality Assurance function at Gilead Sciences, which provides independent oversight for GxP IT Infrastructure & Platforms and manages IT Inspection and audit readiness program. He has over 16 years of diverse experience in biopharmaceutical business ranging from pre-clinical, R&D to manufacturing with leadership expertise on Quality Assurance, Risk Management, Inspection/Audit Management, and Vendor Management. Additionally, as certified Auditor conducted ISO and Part 11/Annex 11 Audits globally. He holds B.E in Electronics & Communication from PSG College of Technology, MS in Electrical Engineering from New Jersey Institute of Technology and Masters in Business Administration (MBA) from Imperial College London.
  • Connie Hetzler, Global Head of Validation, Alcon Laboratories

    Ms. Hetzler has over 32 years of experience working in regulated consumer products and healthcare industry roles. In her current role as Global Head of Validation for Alcon, she is accountable for the validation strategy for 16 manufacturing sites including both the surgical and vision care divisions.
  • Kim Huynh-Ba, Executive Director, Pharmalytik

    Kim Huynh-Ba has over 25 years of experience in quality systems, project management, strategic drug development and stability sciences. She currently is the Executive Director and CEO of Pharmalytik (www.pharmalytik.com), where she provides consulting and training services to pharmaceutical companies. Kim is an Adjunct Professor at Temple University-School of Pharmacy and Illinois Institute of Technology (IIT). She is also a short course instructor on cGMP compliance and quality topics for several global organizations such as American Chemical Society (ACS), American Association of Pharmaceutical Scientists (AAPS), Pittsburgh Conference, and many other international training groups. Kim has authored numerous technical publications, book chapters and has spoken extensively, both domestic and internationally, in the compliance and quality areas. She is the editor of 2 well-known Stability books: the “Handbook of Stability Testing in Pharmaceutical Development: Regulations, Methodologies and Best Practices” (2008) and “Pharmaceutical Stability Testing to Support Global Markets” (2010). She is also working on a manuscript for the textbook “Analytical Chemistry: An Introduction to Pharmaceutical GMP Laboratory,” that is expected to be available in 2019. Kim can be reached at kim.huynhba@pharmalytik.com.
  • Philip Jarvis, Global C&Q Lead, Abbvie

    Mr. Jarvis is an experienced team leader with over 20 years of experience in all areas of validation including; process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation. Through strategic thinking, he has success in steering and managing complex validation projects within the medical device / pharmaceutical / and biologics industries.
  • Steven Kuwahara, Principal Consultant, GXP BioTechnology, LLC

    Steven S. Kuwahara, Ph.D., is principal consultant at GXP BioTechnology, LLC (www.gxpbiotech.org) in Sunnyvale, CA. Steve has more than 30 years experience supervising quality control department dealing with drugs, biologics, HCT/P, and nutraceuticals. He has supervised animal facilities and testing laboratories that operated under GLP rules and also those operating under GMP and ISO standards. He may be reached by e-mail and by phone at 408-530-9338.
  • Matthew LaPierre, Data Integrity Manager, Industry Expert

    Mr. LaPierre is an industry expert and an experienced data integrity project manager. He has a thorough understanding of not only the foundation and principles of data integrity but also the project management tools and resources needed to execute a truly effective data integrity program in the life science industry.
  • Kevin C. Martin, Marketing Partner Azzur, Azzur Group LLC

    Kevin Martin serves as Managing Partner, Azzur Group, LLC and General Manager, Azzur Group IT. Kevin has more than 40 years of FDA-regulated industry experience that includes management positions at Wyeth and McNeil Pharmaceutical. He is currently a General Manager for Azzur IT and a member of the Azzur Group Board of Directors. He was a member of the PhRMA Computer Systems Validation Sub-Committee (responding to the FDA’s issuance of the 1983 “Blue Book”), was the Core Team Secretary for the PDA Part 11 Task Group (working alongside FDA’s Paul Motise to develop industry guidance) and is a former Chair of the GAMP Americas and GAMP Global Steering Committees, and a contributor to several GAMP Good Practice Guides and Special Interest Groups.
  • James Mason, PharmD, Compliance Officer, OPQO, U.S. FDA

    James Mason received his Doctor of Pharmacy degree in 2006 and then served as an officer in the U.S. Air Force. In 2009, he was Commissioned as an officer in the U.S. Public Health Service and began working for FDA as a Field Investigator (CSO) conducting domestic and international drug GMP inspections. In 2016, he became a Pharmaceutical Specialist and now serves as a Compliance Officer for the Office of Pharmaceutical Quality Operations in Parsippany, NJ, where his primary responsibility is handling violative pharmaceutical inspections for FDA regulatory actions. He is a Board Certified Sterile Compounding Pharmacist (BCSCP) and Pharmaceutical GMP professional (ASQ CPGP).
  • Chris Maughan, Managing Director, Thermal Compliance Ltd

    Chris is the Managing Director of Thermal Compliance Ltd, who specialize in the qualification of Thermal Systems. With over 15 years of hands-on validation experience in the Thermal and Biological Validation of Sterilization processes alongside temperature, humidity and CO2 mapping of Controlled Temperature Units. Chris has a detailed knowledge of validation systems and the use of wireless dataloggers, for the Qualification of Thermal Systems.
  • Patrick Mullin, Senior CQV/QAV Consultant, DPS Group Global

    Patrick Mullin has over 15 years of experience in vaccine and biotech operations which include commissioning, qualification, and validation (CQV) management for clinical and commercial scale biotech operations. Patrick's core focus is with the creation, implementation, and maintenance of CQV programs specializing in critical utilities, process equipment (upstream/downstream production and fill finish), process automated systems, and sterilization/cleaning support systems at pilot plant and full commercial scales.
  • Kim Munsell, Senior CSV & Compliance Manager, Janssen R&D

    Kim Munsell is from the Philadelphia area and has worked for Janssen R&D since 2007. She has a bachelor’s degree in biology from Eastern University and a master’s degree in pharmacology from Thomas Jefferson University. She started her career with a short stint as a Quality Control analyst in a GMP pharmaceutical manufacturing plant, and then worked as a protein biochemist and biologic inventory manager in a GLP Janssen BioTherapeutics laboratory for almost 11 years. In 2018, she joined the Lab Operations and Data Systems organization within Janssen BioTherapeutics and was recently promoted into the role of Sr Computer Validation & Compliance Manager. She is passionate about delivering streamlined operational processes and easy-to-use electronic systems that are in compliance with GLP, DDI, and CSV regulations.
  • Donnacha Nagle, Validation Lead, Eirchem Pharmaceuticals

    Donnacha Nagle is a pharmaceutical industry professional based in Ireland and is a recent graduate from the masters degree programme, MSc. in Pharmaceutical Validation Technology, at the Technological University Dublin (TU Dublin). Donnacha is an experienced Validation Engineer with over eleven years of experience in all areas of validation including; Process/Product Validation, Equipment/Automation Qualification, Facilities Qualification, Computer System Validation, Test Method Validation, and Cleaning Validation. Through strategic thinking, he has success in steering and managing complex validation projects within the medical device and pharmaceutical industries. Donnacha has ambitions to become an industry leader within the pharmaceutical industry and is the current Chair of the BPCI Validation group, Ireland. Donnacha is also a recent winner of the 2018 Thesis award presented by KENX at their C&Q and Data Integrity conference, in Dublin, Ireland. Donnacha is also a published author with IVT/JVT, USA.
  • Peju Odunusi, Owner, Pj Pharmceutical Consulting

    Dr. Peju Odunusi is an analytical R&D professional with over 25 years of experience in the pharmaceutical and medical device industries. She has extensive analytical and CMC expertise in product development from inception to launch, with emphasis on “doing it right” the first time. She has successfully established analytical and stability groups in the course of her career, participated in numerous audits and is very passionate about mentoring.
  • Roque, Redondo, VP Business Development Automation, Mirus Consulting Group Corp

    Mr. Roque Redondo has close to 30 years of experience including international experience in the validation, QA, engineering, compliance and regulatory affairs in the life science environment. He was part of the senior management team during the implementation of the remediation activities related to Schering-Plough Consent Decree. His experience includes Data Integrity, operations, serialization, validation, QA, engineering and technical services. Mr. Redondo has attended to over 10 different courses related to Data Integrity as well as he has written 5 articles related to this topic. He has a nice blend of experience, including process and cleaning procedures, that help him understand the importance of manufacturing operations without jeopardizing the quality of the products with strong management skills.
  • Chinmoy Roy, Data Integrity, CSV, Process Automation, VALGENESIS

    Chinmoy Roy is an experienced biopharmaceutical consultant with subject matter expertise in CSV, Data Integrity, CFR 21 Part 11, Annex 11 and manufacturing process automation systems. He is a member of ISPE’s Data Integrity Special Interest Group (S.I.G). His presentations blend his field experience to highlight the intricacies of implementing regulations. Chinmoy has a bachelor’s degree in Electrical Engineer and a Master’s degree in Computer Science.
  • Lelia Scott, Executive Director, Global Quality Systems, Charles River Laboratories

    Ms. Scott is the Executive Director of the Global Quality Systems team at Charles River Laboratories. She has 15 years of progressively challenging QA experience within the pharmaceutical industry and 7 years in analytical lab sciences. She specializes in data integrity compliance, global process adoption, implementation of enterprise-wide quality systems, computer system validation, laboratory systems, relationship building in cross-functional teams and development of innovative solutions to expedite business processes using electronic systems in compliance with global pharmaceutical regulations. Ms. Scott holds a BSc in Chemistry from the University of Western Ontario and an MBA in Pharmaceutical Management from Fairleigh Dickinson University.
  • Ken Shitamoto, MS, Sr. Director IT, Gilead Sciences

    Ken Shitamoto leads the IT quality engineering function at Gilead Sciences, which performs software quality assurance (testing), validation, and infrastructure qualification. He is a multi-disciplined professional with extensive experience in quality engineering, quality management, project management, and software development. He has been in the biopharmaceutical space since 1993 and has worked both on the manufacturer, vendor, and consulting sides of the business. Additionally, he has also performed over 100 GXP computer systems compliance audits globally. He holds a BA Molecular Cell Biology and MS Computer Science and from UC Berkeley and San Jose State University respectively. He is an avid supporter of the American Lung Association, and Ken and his daughter have raised over 130K dollars to fight lung disease.
  • J. Loren Smith, Senior Manager, Global Compliance & Ethics, Computer, BioMarin Pharmaceutical

    Loren has over 28 years of experience specializing in computer systems compliance (from the IT, QA, and Compliance perspectives) in medical device, biotech, pharmaceutical, analytical instrumentation, and software companies. Loren has also been an instructor at University of California, Berkeley, since 2006, teaching computer systems compliance to students in clinical research.
  • Ronald D. Snee, Founder and President, Snee Associates, LLC

    Ron Snee is Founder of Snee Associates, LLC, a firm dedicated to the successful implementation of process and organizational improvement initiatives, using Quality by Design, Lean Six Sigma and other improvement approaches. He is also an Adjunct Professor in the RAQA and pharmaceutical programs at Temple and Rutgers Universities. Prior to entering the consulting field he worked at DuPont for 24 years in a variety of assignments including pharmaceutical development. He is an Honorary Member of the American Society for Quality and has received numerous honors and awards for his research, consulting and publications.
  • Raul Soto, Sr. Principal Software Engineer, Johnson & Johnson

    Raul Soto is a Senior Principal Software Engineer at Johnson & Johnson Vision Care (JJVC), focused on Computerized Systems Validation and Software Quality Engineering. Mr. Soto has over 20 years of experience in validation, process engineering, industrial automation, and software quality; and has held positions of increasing responsibilities in the medical devices, biotechnology, pharmaceutical, and consumer electronics industries. Raul has led multiple global and site projects in the United States, Europe and China. As an invited speaker he has lectured on computer systems validation, data integrity, statistics, PLC/SCADA automation, and quality/compliance issues at various conferences in the United States and Europe. Raul has an MS degree in Biotechnology with emphasis on Biomedical Engineering, and a BS degree in Mechanical Engineering. He is also an ASQ Certified Quality Engineer (CQE).
  • Abhijit Ray, CTO and Co-Founder, Aventior, Inc.

    Abhijit is the CTO and co-founder of Aventior. With over 20 years in technology and working with some of the leading Biotech and Pharma companies, Abhijit has been instrumental is designing new AI solutions for process automation including document processing. Aventior’s solutions for Continued Process Verification and Data Management helps Biotech firms help decrease their efforts in data management, meta-data management and compliance.
  • Fred Ohsiek, Senior Cleaning Validation Specialist, Novo Nordisk

    Fred Ohsiek is the Sr Cleaning Validation Specialist and Cleaning Validation Work Package Owner for Novo Nordisk in Clayton, NC. He earned his bachelor’s in chemistry from University of South Florida. His professional work experience includes 7 years of R&D performing enzymatic digestion, ultrafiltration and fermentation on citrus peel while working for the USDA and 20 years of cleaning validation while working for Catalent Pharma Solutions, Amylin Pharmaceuticals, Ben Venue Laboratories, Teva Pharmaceutical Industries, Astellas Pharma Technologies Bayer (biotech division), and Novo Nordisk. He was considered the cleaning validation subject matter expert in most positions held.

Sponsors


  • A nationwide network of experts delivering professional services across the life sciences industry, Azzur Group is dedicated to providing clients with efficient, innovative quality and compliance solutions from Discovery to Delivery™. With more than 250 industry partners, including 80% of the top pharma/biotech manufacturers in the U.S., Azzur Group provides carefully calibrated and efficiently executed project management, process engineering, and compliance services. As one of the fastest growing private companies in America, Azzur Group provides clients with the consulting, facility solutions, engineering, validation, IT, technical, training, and laboratory services and solutions they need to remain innovative and competitive.
    Website: https://www.azzur.com/
  • Since 1949, Ellab is a leading manufacturer of a full line of wireless, real-time data loggers and wired thermocouple validation systems with temperature, humidity, pressure, vacuum, conductivity and CO2 sensor options. Additionally, Ellab offers temperature standards, calibration dry blocks and liquid baths, custom fittings, accessories, and thermocouples. We also offer on-site qualification, validation and calibration services for thermal validation processes ranging from -196°C to 400°C. Typical environments often include -80°C freezers, incubators, stability chambers, autoclaves, and ovens.
    Website: https://www.ellab.com/

  • For almost sixty years, Kaye has been at the forefront of high accuracy process measurement. For applications from thermal process validation and environmental monitoring, to sensor calibration, Kaye technology has provided the most accurate and user friendly measuring systems available in the market today.
    Website: https://www.kayeinstruments.com/en/

  • Aventior (www.aventior.ai) is an AI and Data Science company that is building data management and process automation solutions for the life sciences industry. Its CPV Automation (“CPV Auto”) platform uses AI-assisted technologies to process batch records that are either printed, scanned or hand-written. Through this automation, Aventior has reduced document processing times by over 75%. Some of the leading biotech firms use this platform to reduce their dependency on manual effort, decrease their data collection efforts, reduce errors and reduce the time to stay FDA compliant.
    Website: www.aventior.ai
  • H&A Scientific, Inc. is a scientific software development firm specializing in pharmaceutical industry support. We develop, validate, and market quality computing systems for scientific data acquisition, processing, and data management. We have been creating programs for the laboratory since 1992. Our products have been designed under our Quality System to adhere to the current GAMP guidelines. We develop Quality Software products based on the needs of pharmaceutical companies subject to the constraints and compliance of the Food and Drug Administration (FDA). Our flagship product, SLIM, is a commercial off-the-shelf solution for total management of a company's drug stability program.
    Website: http://www.hascientific.com/en/

Partners

    More Information To Follow Soon

Venue

Details

Start:
March 30
End:
April 1
Event Category:

Venue

Wyndham Philadelphia Historic District
400 Arch Street
Philadelphia, PA 19106 United States
+ Google Map
Phone:
(215) 923-8660
Website:
http://www.phillydowntownhotel.com/

Pricing & Registration

opt-in below for event updates